Endothelial deletion of SHP2 suppresses tumor angiogenesis and promotes vascular normalization
SHP2 regulates pro-angiogenic VEGF-VEGFR signalling, but its role in tumour angiogenesis is unclear. Here the authors show that endothelial cell-specific deletion of SHP2 impairs tumour growth and angiogenesis in syngeneic mouse models through ASK1-c-JunSOX7 signalling axis.
Guardado en:
Autores principales: | Zhiyong Xu, Chunyi Guo, Qiaoli Ye, Yueli Shi, Yihui Sun, Jie Zhang, Jiaqi Huang, Yizhou Huang, Chunlai Zeng, Xue Zhang, Yuehai Ke, Hongqiang Cheng |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3b558ae5e336405a9be16f4647d6437b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Endothelial specific YY1 deletion restricts tumor angiogenesis and tumor growth
por: Huan Liu, et al.
Publicado: (2020) -
Effects of palmitic acid and eicosapentaenoic acid on angiogenesis of porcine vascular endothelial cells
por: Jie Peng, et al.
Publicado: (2021) -
Endothelial deletion of Ino80 disrupts coronary angiogenesis and causes congenital heart disease
por: Siyeon Rhee, et al.
Publicado: (2018) -
miRNA-27b targets vascular endothelial growth factor C to inhibit tumor progression and angiogenesis in colorectal cancer.
por: Jun Ye, et al.
Publicado: (2013) -
SHP-2 deletion in CD4Cre expressing chondrocyte precursors leads to tumor development with wrist tropism
por: Jeffrey T. McNamara, et al.
Publicado: (2021)